For the Quarter Ending September 2025
North America
• In United States, the Lidocaine Hydrochloride Price Index rose quarter-over-quarter in Q3 2025, driven by increasing production costs and robust consumer spending.
• Lidocaine Hydrochloride production costs increased in Q3 2025, influenced by rising o-Xylene feedstock and a 2.6% PPI increase in August 2025.
• Demand for Lidocaine Hydrochloride was supported by a 5.42% retail sales increase in September 2025, boosting OTC products.
• A low unemployment rate of 4.3% in September 2025 supported higher healthcare utilization, positively impacting Lidocaine Hydrochloride demand.
• The 3.0% year-over-year CPI increase in September 2025 elevated overall operational expenses for Lidocaine Hydrochloride manufacturers.
• New drug approvals in US pharmaceutical market in Q3 2025, especially gene and cell therapy, supported Lidocaine Hydrochloride demand.
• Lidocaine Hydrochloride price forecast suggests upward pressure from sustained input cost increases and steady demand in key sectors.
Why did the price of Lidocaine Hydrochloride change in September 2025 in North America?
• Rising o-Xylene feedstock costs and 2.6% PPI increase in August 2025 elevated production expenses.
• Robust consumer spending, with 5.42% retail sales increase in September 2025, boosted OTC demand.
• Industrial production increased marginally by 0.1% in September 2025, while consumer confidence declined to 94.2.
APAC
• In China, the Lidocaine Hydrochloride Price Index declined quarter-over-quarter in Q3 2025, influenced by falling producer prices and contracting manufacturing.
• Lidocaine Hydrochloride production costs decreased in September 2025, driven by a 2.3% year-over-year fall in producer prices.
• Petrochemical feedstock prices remained stable in Q3 2025, providing stability to Lidocaine Hydrochloride input costs.
• Demand for Lidocaine Hydrochloride faced pressure from a 0.3% year-over-year decline in consumer prices in September 2025.
• Industrial production expanded 6.5% year-over-year in September 2025, supporting API demand despite contracting manufacturing.
• Retail sales increased 3.0% year-over-year in September 2025, positively impacting consumer-facing Lidocaine Hydrochloride product demand.
• Low consumer confidence (89.6 in September 2025) and a 5.2% unemployment rate dampened discretionary spending.
• China's pharmaceutical market growth, fueled by an aging population, continued to support Lidocaine Hydrochloride consumption.
• Global chemical overcapacity persisted in Q3 2025, contributing to ample inventories for basic chemical inputs.
Why did the price of Lidocaine Hydrochloride change in September 2025 in APAC?
• Producer prices declined 2.3% year-over-year in September 2025, reducing Lidocaine Hydrochloride manufacturing costs.
• Consumer prices fell 0.3% year-over-year in September 2025, reflecting weak consumer demand.
• Manufacturing activity contracted in September 2025, slowing overall industrial demand.
Europe
• In Germany, the Lidocaine Hydrochloride Price Index fell quarter-over-quarter in Q3 2025, influenced by declining producer prices.
• Lidocaine Hydrochloride production costs decreased in September 2025, driven by a 1.7% year-over-year decline in producer prices.
• European ethanol feedstock costs, relevant for Lidocaine Hydrochloride, were rising in Q3 2025 due to increasing natural gas prices.
• Lidocaine Hydrochloride demand outlook remained stable, supported by a 0.2% rise in retail sales in September 2025.
• Germany's pharmaceutical market experienced moderate growth in Q3 2025, sustaining Lidocaine Hydrochloride demand.
• Overall industrial activity in Germany was contracting in Q3 2025, with industrial production down 1.0% year-over-year.
• Ample O-xylene inventories in Europe during Q3 2025 contributed to stable feedstock availability for Lidocaine Hydrochloride.
• Wholesale electricity prices in Germany increased in Q3 2025, impacting Lidocaine Hydrochloride manufacturing operational costs.
• Healthcare expenditure in Germany showed a gradual increase in Q3 2025, supporting Lidocaine Hydrochloride market stability.
Why did the price of Lidocaine Hydrochloride change in September 2025 in Europe?
• Producer prices for industrial products declined 1.7% in September 2025, reducing Lidocaine Hydrochloride manufacturing costs.
• Germany's Manufacturing Index was contracting in Q3 2025, reflecting a weaker industrial environment and dampening demand.
• Rising European ethanol feedstock costs and increased wholesale electricity prices in Q3 2025 exerted upward pressure on production expenses.
